News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Jiren’s career spanned over 30 years as an entrepreneur, C-level and Senior Executive and included founding, scaling and supporting technology businesses.
Launched in 2021, Vivodyne’s platform allows fully automated, complex studies at a far larger scale and lower cost than would be possible with manual experimentation.
Several new research studies reported in the New York Times have demonstrated that multiple doses of a COVID vaccine elicit a durable response in most people that protects them from serious illness
Olivia McPherson, Program Manager, JPOD@PHILADELPHIA, shares how the JPOD and Johnson & Johnson's JLABS program helps startups with life science commercialization.
Penn Engineering secured a multi-million-dollar contract with Wellcome Leap under the organization’s $60 million RNA Readiness + Response (R3) program.
This webinar discusses the latest trends in intellectual property and patenting for engineers, including robotics, nanotechnology, med-tech and more
A new study reports three distinct proteins in human plasma that have naturally occurring antibiotic properties. Global public health officials are concerned about the r
John Q. Trojanowski, MD, PhD is remembered as a neuroscience pioneer.
Gutmann spearheaded the creation of an innovation ecosystem for Penn, Philadelphia, and beyond by transforming technology transfer at Penn to be both more faculty- and industry-friendly.